Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years – PROTECT Cohort, July 2021-February 2022
On March 11, 2022, this report was posted online as an MMWR Early Release. Ashley L. Fowlkes, ScD1; Sarang K. Yoon, DO2; Karen Lutrick, PhD3; Lisa Gwynn,